 
MAINE STATE LEGISLATURE  
 
 
 
The following document is provided by the 
LAW AND LEGISLATIVE DIGITAL LIBRARY  
at the Maine State Law and Legislative Reference Library 
http://legislature.m aine.gov/lawlib 
 
 
 
 
 
 
 
 
 
 
Reproduced from electronic originals 
(may include minor formatting diffe rences from printed original) 
 
 
Printed on recycled paper128th MAINE LEGISLATURE
FIRST REGULAR SESSION-2017
Legislative Document No. 265
H.P. 198 House of  Representatives, January 31, 2017
An Act  Concerning Screening of  Newborns for Lysosomal Storage 
Disorders
Reference to the Committee on Health  and Human Services suggested and  ordered printed.
ROBERT  B. HUNT
Clerk
Presented by Representative JOHANSEN of Monticello.
Cosponsored by Senator CARPENTER of Aroostook and
Representatives: BRADSTREET  of Vassalboro, HARVELL of Farmington, McELWEE of 
Caribou, STEWART of Presque Isle, WARD of Dedham.

 
 Page 1 - 128LR1014(01) -1 
 Be it enacted by the People of the State of Maine as follows:  1 
Sec. 1.  22 MRSA §1533, sub -§2, ¶D -1 is enacted to read:  2 
D-1.  Explore options for entering into contracts with other states to test samples 3 
collected during screening for lysosomal storage diso rders;  4 
Sec. 2.  Department of Health and Human Services to amend rules on the 5 
newborn screening program.  By January 1, 2018, the Department of Health and 6 
Human Services shall amend its rules in Chapter 283 relating to testing newborn infants 7 
for detection  of causes of cognitive disabilities and selected genetic conditions to include 8 
screening for the lysosomal storage disorders known as Krabbe, Pompe, Gaucher, Fabry 9 
and Niemann -Pick diseases.  10 
SUMMARY  11 
This bill requires the Department of Health and Human Se rvices to amend its rules in 12 
Chapter 283 relating to the newborn screening program by January 1, 2018 to add to the 13 
program the lysosomal storage disorders known as Krabbe, Pompe, Gaucher, Fabry and 14 
Niemann -Pick diseases.  It directs the department to expl ore options to enter into 15 
contracts with other states to test samples collected for lysosomal storage disorders.  16 
 
